Reforming Global Health in an age of fragmentation

Nearly three months after the closing gavel fell at the 79th World Health Assembly (WHA79) in Geneva, the diplomatic dust has settled, leaving behind a clear view of the complex implementation work ahead. For the global health ecosystem and European academic networks like EGHRIN, taking stock of the assembly’s outcomes is essential to understanding how international policy directly conditions research funding, data-sharing protocols, and equitable scientific partnerships.

 

Governance Reform: Political Challenges and Structural Friction

The defining outcome of WHA79 was the formal approval of a WHO-led governance reform process aimed at decentralizing decision-making and building regional scientific capacity. However, translating this resolution into real-world progress requires a level of political momentum that remains a formidable challenge.

This political deadlock is most evident in the ongoing difficulties to finalize and approve the critical annexes to the WHO Pandemic Agreement, specifically the Pathogen Access and Benefit-Sharing (PABS) system. Tensions between the Global North and South over equitable access to biological data, medical countermeasures, and technology transfer demonstrate that structural divides remain unaddressed.

This governance bottleneck is further compounded by a fragile financial architecture still heavily reliant on short-term, earmarked voluntary contributions. Without predictable baseline funding, setting independent, evidence-based research priorities remains difficult. 

Meanwhile, side debates at WHA79 highlighted three interconnected drivers that are reshaping the research landscape:

 

Strategic Implications for the EGHRIN Network

The post-WHA79 landscape demonstrates that global health research cannot operate in isolation from international policy reforms. For EGHRIN and its member institutions, this environment highlights three operational priorities: